Q2 2026 Holdings
Filed 2026-08-14 | 35 holdings | $20.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CUE Biopharma Inc(CUE) | COM | 22978P205 | $1.7M | 52,928 | 8.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $1.5M | 4,450 | 7.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $1.3M | 67,500 | 6.3% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $1.2M | 112,434 | 5.8% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $1.2M | 21,400 | 5.7% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $1.1M | 80,000 | 5.4% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $1.1M | 820,000 | 5.3% |
| Benitec Biopharma Inc(BNTC) | COM NEW | 08205P209 | $829.6K | 62,000 | 4.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $787.0K | 36,000 | 3.8% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $769.3K | 51,700 | 3.7% |
| Geron Corp(GERN) | COM | 374163103 | $739.8K | 578,000 | 3.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $677.1K | 14,700 | 3.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $656.1K | 128,650 | 3.1% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $610.2K | 5,500 | 2.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $592.4K | 8,100 | 2.8% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $512.1K | 28,500 | 2.4% |
| Humacyte Inc(HUMA) | COM | 44486Q103 | $507.3K | 650,000 | 2.4% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $504.6K | 46,000 | 2.4% |
| Viatris Inc(VTRS) | COM | 92556V106 | $439.9K | 27,700 | 2.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $399.8K | 18,000 | 1.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $372.4K | 5,000 | 1.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $369.7K | 9,100 | 1.8% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $342.5K | 13,500 | 1.6% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $318.7K | 26,600 | 1.5% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $294.1K | 86,000 | 1.4% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $291.8K | 19,000 | 1.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $283.3K | 10,500 | 1.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $274.2K | 10,200 | 1.3% |
| Seres Therapeutics Inc(MCRB) | COM NEW | 81750R201 | $249.1K | 31,570 | 1.2% |
| Azenta Inc(AZTA) | COM | 114340102 | $247.5K | 9,700 | 1.2% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $195.8K | 465,000 | 0.9% |
| Innoviva Inc(INVA) | COM | 45781M101 | $186.2K | 8,200 | 0.9% |
| Innate Pharma S A(IPHA) | SPONSORED ADS | 45781K204 | $149.3K | 81,151 | 0.7% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $137.7K | 5,250 | 0.7% |
| Spruce Biosciences Inc(SPRB) | COM NEW | 85209E208 | $54.0K | 1,000 | 0.3% |